491 related articles for article (PubMed ID: 33757485)
1. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
Barjaktarevic I; Miravitlles M
BMC Pulm Med; 2021 Mar; 21(1):99. PubMed ID: 33757485
[TBL] [Abstract][Full Text] [Related]
2. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
3. Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease.
Piloni D; Ottaviani S; Saderi L; Corda L; Baderna P; Barzon V; Balderacchi AM; Seebacher C; Balbi B; Albicini F; Corino A; Mennitti MC; Tirelli C; Spreafico F; Bosio M; Mariani F; Sotgiu G; Corsico AG; Ferrarotti I
Minerva Med; 2024 Feb; 115(1):23-31. PubMed ID: 37021471
[TBL] [Abstract][Full Text] [Related]
4. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
Fromme M; Hamesch K; Schneider CV; Mandorfer M; Pons M; Thorhauge KH; Pereira V; Sperl J; Frankova S; Reichert MC; Benini F; Burbaum B; Kleinjans M; Amzou S; Rademacher L; Bewersdorf L; Verbeek J; Nevens F; Genesca J; Miravitlles M; Nuñez A; Schaefer B; Zoller H; Janciauskiene S; Waern J; Oliveira A; Maia L; Simões C; Mahadeva R; Fraughen DD; Trauner M; Krag A; Lammert F; Bals R; Gaisa NT; Aigner E; Griffiths WJ; Denk H; Teumer A; McElvaney NG; Turner AM; Trautwein C; Strnad P
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):283-294.e5. PubMed ID: 37716616
[TBL] [Abstract][Full Text] [Related]
7. alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note.
Sandhaus RA; Turino G; Stocks J; Strange C; Trapnell BC; Silverman EK; Everett SE; Stoller JK;
Chest; 2008 Oct; 134(4):831-834. PubMed ID: 18842915
[TBL] [Abstract][Full Text] [Related]
8. Clinical considerations in individuals with α
McElvaney GN; Sandhaus RA; Miravitlles M; Turino GM; Seersholm N; Wencker M; Stockley RA
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32165400
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
[TBL] [Abstract][Full Text] [Related]
10. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
Campos MA; Lascano J
Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
[TBL] [Abstract][Full Text] [Related]
11. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.
Greulich T; Albert A; Cassel W; Boeselt T; Peychev E; Klemmer A; Ferreira F; Clarenbach C; Torres-Duran ML; Turner AM; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2022; 17():53-64. PubMed ID: 35023913
[TBL] [Abstract][Full Text] [Related]
12. PredictAAT: Accounting for Inflammation in the Diagnosis of Alpha 1 Antitrypsin Deficiency.
Kueppers F
COPD; 2020 Dec; 17(6):619-622. PubMed ID: 32862719
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-antitrypsin deficiency: forgotten etiology.
Kaplan A; Cosentino L
Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
[TBL] [Abstract][Full Text] [Related]
14. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
16. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
Tonelli AR; Brantly ML
Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
[TBL] [Abstract][Full Text] [Related]
17. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.
Bull World Health Organ; 1997; 75(5):397-415. PubMed ID: 9447774
[TBL] [Abstract][Full Text] [Related]
19. Sanger sequencing solved a cryptic case of severe alpha₁-antitrypsin deficiency.
Zhan SH; Abboud RT; Jung B; Kuchinka B; Ralston D; Casey B; Mattman A
Clin Biochem; 2012 Apr; 45(6):499-501. PubMed ID: 22330941
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
